Abstract Background Age-related maculopathy (ARM) is a leading cause of vision loss in people aged 65 or older. ARM is distinctive in that it is a disease which can transition through incidence, progression, regression and disappearance. The purpose of this study is to develop methodologies for studying the relationship of risk factors with different transition probabilities. Methods Our framework for studying this relationship includes two different analytical approaches. In the first approach, one can define, model and estimate the relationship between each transition probability and risk factors separately. This approach is similar to constraining a population to a certain disease status at the baseline, and then analyzing the probabilit...
textabstractIn 1875, Pagenstecher and Gentll provided the first description of age-related maculopat...
Purpose Prediction models for age-related macular degeneration (AMD) based on case-control studies h...
A major goal of personalized medicine is to pre-symptomatically identify individuals at high risk fo...
Background: Age-related maculopathy (ARM) is a leading cause of vision loss in people aged 65 or old...
PURPOSE. To describe the incidence rate of age-related macular degeneration (AMD) and the progressio...
To evaluate the natural course of age-related maculopathy (ARM) and to assess the incidence and abso...
The number of people in the United States with age-related maculopathy is increasing in recent years...
textabstractThe western world is aging rapidly. In the Netherlands, the current mean life expectanc...
Purpose: Prediction models for age-related macular degeneration (AMD) based on case-control studies ...
textabstractIn the 19th century, age-related maculopathy (ARM) was described for the first time as a...
© 2018 Dr Myra McGuinnessBackground:Age-related macular degeneration (AMD) is the most common cause ...
A major goal of personalized medicine is to pre-symptomatically identify individuals at high risk fo...
A major goal of personalized medicine is to pre-symptomatically identify individuals at high risk fo...
Purpose Prediction models for age-related macular degeneration (AMD) based on case-control studies h...
Prediction models for age-related macular degeneration (AMD) based on case-control studies have a te...
textabstractIn 1875, Pagenstecher and Gentll provided the first description of age-related maculopat...
Purpose Prediction models for age-related macular degeneration (AMD) based on case-control studies h...
A major goal of personalized medicine is to pre-symptomatically identify individuals at high risk fo...
Background: Age-related maculopathy (ARM) is a leading cause of vision loss in people aged 65 or old...
PURPOSE. To describe the incidence rate of age-related macular degeneration (AMD) and the progressio...
To evaluate the natural course of age-related maculopathy (ARM) and to assess the incidence and abso...
The number of people in the United States with age-related maculopathy is increasing in recent years...
textabstractThe western world is aging rapidly. In the Netherlands, the current mean life expectanc...
Purpose: Prediction models for age-related macular degeneration (AMD) based on case-control studies ...
textabstractIn the 19th century, age-related maculopathy (ARM) was described for the first time as a...
© 2018 Dr Myra McGuinnessBackground:Age-related macular degeneration (AMD) is the most common cause ...
A major goal of personalized medicine is to pre-symptomatically identify individuals at high risk fo...
A major goal of personalized medicine is to pre-symptomatically identify individuals at high risk fo...
Purpose Prediction models for age-related macular degeneration (AMD) based on case-control studies h...
Prediction models for age-related macular degeneration (AMD) based on case-control studies have a te...
textabstractIn 1875, Pagenstecher and Gentll provided the first description of age-related maculopat...
Purpose Prediction models for age-related macular degeneration (AMD) based on case-control studies h...
A major goal of personalized medicine is to pre-symptomatically identify individuals at high risk fo...